S100A4 and intrahepatic cholangiocarcinoma: In contrast, a low expression of S100A4 was observed in the tumor mesenchyme by IHC (10% positive), which was comparable to the ICC expression (<1% positive) of the same markers in the tumor-derived CAFs (compare Figure 2B and Figure 5E left and right panel).